CareCloud (MTBC) Q3 2024 earnings summary

Executive summary

• Q3 2024 revenue was $28.5M, down 2.5–3% year-over-year, with nine-month revenue at $82.6M, down 6.8–7% from 2023.

• Achieved record free cash flow of $10.3M for the first nine months, up 328–391% year-over-year, and fully repaid a $10M credit line.

• Returned to profitability with $3.1M GAAP net income in Q3 2024, reversing a $2.7M loss in Q3 2023; nine-month net income was $4.6M versus a $5.0M loss last year.

• Significant cost reductions and restructuring, targeting $26M in expense cuts by year-end, with $20M realized in 2024.

• Advanced AI-driven solutions, notably cirrusAI, to enhance operational efficiency and client satisfaction.

Financial highlights

• Q3 2024 adjusted EBITDA was $6.8M (24% margin), up 111–113% year-over-year; nine-month adjusted EBITDA was $16.9M, up 50%.

• Q3 free cash flow was $5.4M, up 391–405% year-over-year; nine-month free cash flow was $10.3M, up 328%.

• Operating expenses fell 19% year-over-year in Q3, driven by lower direct costs, marketing, G&A, and R&D.

• Q3 2024 adjusted operating margin was 12.9% (vs. 1.8% in Q3 2023); nine-month margin was 9.1%.

• Cash at September 30, 2024 was $2.8M; net working capital was $732,000.

Outlook and guidance

• Full-year 2024 revenue guidance reaffirmed at $109–$111M; adjusted EBITDA guidance increased to $23–$25M.

• Expects to resume preferred dividends on Series A and B shares in March 2025.

• Focus for 2025 will shift to strengthening recurring revenue and pursuing disciplined, profitable growth, especially through AI and remote patient monitoring.